Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

By Guarneri Valentina  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

By Walter Christian   Grötz Knut   Kunkel Martin   Al-Nawas Bilal  

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study

By Perrotta I.   Cristofaro M. G.   Amantea M.   Russo E.   De Fazio S.   Zuccalà V.   Conforti F.   Amorosi A.   Donato G.   Tripepi S.   Giudice M.  

Ultrastructural Pathology, Vol. 34, Iss. 4, 2010-08 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

The Phenomenon of Osteonecrosis of the Jaw in Patients with Metastatic Breast Cancer

By Poznak Catherine  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 110-112

Informa Healthcare

Access to resources Recommend Favorite

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

By Coleman R.  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite